Oddifact is an innovative biotech platform accelerating therapeutic innovation in rare diseases through strategic biologics repositioning and advanced AI-driven regulatory intelligence. Leveraging proprietary Retrieval-Augmented Generation algorithms, Oddifact transforms extensive clinical data into actionable therapeutic and regulatory assets, rapidly unlocking value from science to market. Our multidisciplinary team of senior clinical, regulatory, data-science, and financial experts operates internationally (North America & Europe), partnering closely with leading biotech firms and healthcare investors to shape next-generation therapeutic development.
| Website | https://www.oddifact.com/ |
| Employees | 6 (3 on RocketReach) |
| Industry | Biotechnology Research |
| Keywords | Biosimilars, Rare Diseases, Medical Research, Drug Repurposing, Pharmaceutical Development, Unmet Medical Needs, Biotechnology, Drug Innovation, Lifecycle Management, Clinical Trials, Regulatory Affairs, Healthcare, Drug Manufacturing, Precision Medicine, Pharmaceutical, Research And Development, Drug Discovery |
| Competitors | Sprout Social, Inc., Hootsuite, Agorapulse, Buffer, Mavrck, Bob Angelo Test SRL, CoSchedule, BuzzSumo, MeetEdgar, SocialOomph +43 more (view full list) |
Looking for a particular ODDIFACT employee's phone or email?
Pierre-Alexandre Teulié is the CEO of ODDIFACT.
3 people are employed at ODDIFACT.